ZimmermanAWJyonouchiHComiAMConnorsSLMilstienSVarsouAet al
Positioned for the deep longevity patient
Pulmonary Conditions GHK-Cu has shown promising results in the treatment of bleomycin-induced pulmonary fibrosis, a model for idiopathic pulmonary fibrosis (IPF)
WADA prohibits BPC-157 at all times under S0 Non-Approved Substances and names it explicitly
This is important in laboratory studies, as LPS can interfere with experimental outcomes and immune-response measurements in research models
But what's interesting is with performance based individuals, myself included, much like yourself, we're on podcasts, we're doing conferences, seminars, speaking engagements